Dose-Dependent Cellular Phenotypic Change Induced by <sup>177</sup>Lu-Oxodotreotide Treatment in IMR-32 Cells
<b>Objectives</b>: Beta-emitting radionuclide therapy, exemplified by <sup>177</sup>Lu-Oxodotreotide (Lutathera<sup>®</sup>), enables targeted treatment of neuroendocrine tumors by delivering β-radiation to tumor cells. However, the dose-dependent molecular mechan...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-06-01
|
| Series: | Biomedicines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9059/13/7/1543 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|